1. Home
  2. PHIN vs TMDX Comparison

PHIN vs TMDX Comparison

Compare PHIN & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PHINIA Inc.

PHIN

PHINIA Inc.

HOLD

Current Price

$75.71

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$68.86

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHIN
TMDX
Founded
2023
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
PHIN
TMDX
Price
$75.71
$68.86
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
$70.00
$148.22
AVG Volume (30 Days)
466.4K
1.1M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
1.66%
N/A
EPS Growth
84.09
382.18
EPS
0.96
0.20
Revenue
N/A
$605,494,000.00
Revenue This Year
$6.35
$24.25
Revenue Next Year
$2.29
$18.75
P/E Ratio
$78.86
$344.30
Revenue Growth
N/A
37.13
52 Week Low
$46.78
$60.11
52 Week High
$86.94
$156.00

Technical Indicators

Market Signals
Indicator
PHIN
TMDX
Relative Strength Index (RSI) 41.17 42.66
Support Level $68.81 $64.90
Resistance Level $81.04 $71.14
Average True Range (ATR) 3.00 4.00
MACD -0.78 -0.31
Stochastic Oscillator 14.99 25.29

Price Performance

Historical Comparison
PHIN
TMDX

About PHIN PHINIA Inc.

Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, it generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: